Shares of Thermo Fisher Scientific Inc. TMO rose 1.86% to $561.71 Thursday, on what proved to be an all-around rough trading ...

Brookstone Capital Management cut its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 8.9% in the fourth ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $551.47 which represents a decrease of $-5.52 or -0.99% from the prior close of $556.99. The stock opened at $557.88 and ...

Lyndra secured $101m in Series E financing to advance its pipeline of long-lasting oral therapy products. "Lyndra and Thermo ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to ...

We recently published a list of 12 Best Safe Dividend Stocks for 2025. In this article, we are going to take a look at where ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

The LYNX technology originated in the Traverso and Langer Laboratories at MIT, with which Lyndra has an exclusive technology license.

As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is ...

An academic journal has retracted a study conducted by researchers with the science services giant Thermo Fisher Scientific ...

Shares of Thermo Fisher Scientific Inc. TMO inched 0.26% higher to $556.99 Tuesday, on what proved to be an all-around ...